The Effect of LL37 Antimicrobial Peptide on FOXE1 and lncRNA PTCSC 2 Genes Expression in Colorectal Cancer (CRC) and Normal Cells
Authors:
Open Access
- 1 October 2022
- journal article
- research article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 23 (10) , 3437-3442
Abstract
Objective: As an innate immune system component, antimicrobial peptides (AMPs) exert various effects, such as anticancer properties. This study aimed to evaluate the LL37 AMP anticancer effect against colorectal cancer (CRC) cells and the expression of FOXE1 and lncRNA PTCSC2 genes. Methods: The LL37 AMP was purchased from GenScript USA, Inc. Various CRC cell lines (HCT-116, HT29, WiDr, and SW742) were cultured in the DMEM medium. Various concentrations ranging from (5-400) μg/mL of LL37 AMP were prepared, added to cell cultures, and incubated for (24 and 48) hours. A nontoxic level of 30 µg/mL of LL37 was investigated for FOXE1 and lncRNA PTCSC2 gene expression. Results: At 24 hours, the (50 and 90) % lethal concentrations of LC50 and LC90, respectively, of LL37 against NCM460 normal cells were (640 and > 640) g/mL. Additionally, these values at 48 hours included (160 and > 640) µg/mL, respectively. After 24 hours of treatment, the LC50 and LC90 of LL37 AMP against CRC cell lines included (20 and 200) µg/mL. The LC50 and LC90 of the LL37 at 48 hours included (20 and 50) µg/mL and at 72 hours. they included (~10 and 40) μg/mL, respectively. FOXE1 but not the PTCSC 2 gene expression was significantly higher in CRC cells than normal cells (NCM460 and HaCaT). The LL37 AMP significantly decreased FOXE1 gene expression by 1.95-fold in CRC cells (p < 0.001). Conclusion: The FOXE1 gene can be considered a biomarker of CRC development. The expression of FOXE1 but not the PTCSC2 gene was significantly affected by the LL37 AMP. The effects of LL37 AMP against CRC cells were time and dose-dependent. Future studies are warranted to verify these effects.Keywords
This publication has 19 references indexed in Scilit:
- Human antimicrobial peptides and cancerSeminars in Cell & Developmental Biology, 2019
- FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β‐catenin pathwayJournal of Cellular Physiology, 2019
- Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome AtlasMolecular Cancer Research, 2019
- Anticancer Activity of the Goat Antimicrobial Peptide ChMAP-28Frontiers in Pharmacology, 2018
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 2017
- Measuring cancer evolution from the genomeThe Journal of Pathology, 2016
- Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 libraryNature Biotechnology, 2016
- Combination Effects of Antimicrobial PeptidesAntimicrobial Agents and Chemotherapy, 2016
- Novel Antimicrobial Peptides with High Anticancer Activity and SelectivityPLOS ONE, 2015
- Long Intergenic Non-Coding RNAs (LincRNAs) Identified by RNA-Seq in Breast CancerPLOS ONE, 2014